AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer
Tue, 18 Mar 2008 3:00pm
ARANA THERAPEUTICS LIMITED (AAH)
Loading presentation... If nothing happens, you may need to install
Flash and/or enable javascript in your browser.
BROADCAST INFORMATION
email presenter
share this
AAH - CEO Profile - Dr Steffen Nock, Acting CEOMon, 15 Dec 2008 9:30am
AAH - Arana Commences International Phase II Rheumatoid Arthritis Trial - Dr David Fuller, Chief Medical Officer
Wed, 19 Nov 2008 10:30am
Wed, 19 Nov 2008 10:00am
Thu, 13 Nov 2008 4:30pm
Tue, 4 Nov 2008 9:30am
Thu, 28 Aug 2008 4:30pm
ART621 Reaches Key Milestone 
Thu, 3 Jul 2008 12:00pm
